Efficacy of New Silver-coated Prosthesis in Reducing the Incidence of Periprosthetic Infections
Launched by ISTITUTO ORTOPEDICO RIZZOLI · Mar 14, 2025
Trial Information
Current as of April 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new type of hip prosthesis, or artificial joint, that is coated with a special silver material. The purpose of the study is to find out if this silver coating can help prevent infections that can happen around the hip joint during and after surgery. Infections can be a serious concern for patients, especially those who may have weakened immune systems or conditions like diabetes.
To participate in this trial, you need to be at least 18 years old and able to provide your consent. The study is open to everyone, including those with health issues that may increase their risk for infections. If you decide to join, you will be closely monitored to see how well the silver-coated prosthesis works in preventing infections. The trial is currently recruiting participants, and your involvement could help improve treatment options for future patients facing similar challenges.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients aged ≥ 18 years;
- • Immunocompromised patients and/or diabetic patients.
- • Patients who have given consent
- Exclusion Criteria:
- • Patients aged \< 18 years;
- • Pregnant women;
About Istituto Ortopedico Rizzoli
Istituto Ortopedico Rizzoli is a renowned orthopedic research and treatment institute based in Bologna, Italy, dedicated to advancing musculoskeletal health through innovative clinical trials and cutting-edge medical practices. With a strong emphasis on research, the institute collaborates with leading experts in orthopedics, rehabilitation, and related fields to develop and evaluate new therapies and surgical techniques. Committed to improving patient outcomes, Istituto Ortopedico Rizzoli not only focuses on high-quality clinical care but also fosters a robust research environment that supports the translation of scientific findings into clinical applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bologna, Bo, Italy
Argenta, Italia, Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported